Login
$CRVO
$2.22 -$0.02 (0.89%) Close

$CRVO 4 SEC Filings

Filed On Filing
23 Oct 2026 Form 4: Blackburn Kelly, EVP, Clinical Development

Granted 19,100 Stock Option (Right to Buy)

23 Oct 2026 Form 4: De Rosch Mark, EVP, RA and GA and PgM

Granted 19,100 Stock Option (Right to Buy)

23 Oct 2026 Form 4: Winton Matthew, Chief Commercial and Business

Granted 19,100 Stock Option (Right to Buy)

15 Jun 2026 Form 4: Boger Joshua S, Director

Bought 955,414 shares ($3M) · Acquired 955,414 Series B Warrants (Open Market Purchase) · Acquired 955,414 Series C Warrants (Open Market Purchase)

10 Jun 2026 Form 4: Zavrl Frank, Director

Granted 8,150 Stock Option (Right to Buy)

10 Jun 2026 Form 4: Sabbagh Marwan, Director

Granted 8,150 Stock Option (Right to Buy)

10 Jun 2026 Form 4: Quigley David, Director

Granted 8,150 Stock Option (Right to Buy)

10 Jun 2026 Form 4: Poulton Jeffrey V., Director

Granted 8,150 Stock Option (Right to Buy)

10 Jun 2026 Form 4: Hollingsworth Jane H, Director

Granted 8,150 Stock Option (Right to Buy)

10 Jun 2026 Form 4: Gregoire Sylvie, Director

Granted 8,150 Stock Option (Right to Buy)

10 Jun 2026 Form 4: Boger Joshua S, Director

Granted 8,150 Stock Option (Right to Buy)

10 Jun 2026 Form 4: Alam John J, Director

Granted 8,150 Stock Option (Right to Buy)

13 Feb 2026 Form 4: Winton Matthew, Chief Commercial and Business

Granted 30,000 Stock Option (Right to Buy)

13 Feb 2026 Form 4: Gregoire Sylvie, Director

Granted 75,000 Stock Option (Right to Buy)

13 Feb 2026 Form 4: Elder William Robert, CFO, GC & Secretary

Granted 30,000 Stock Option (Right to Buy)

13 Feb 2026 Form 4: De Rosch Mark, EVP, RA and GA and PgM

Granted 30,000 Stock Option (Right to Buy)

13 Feb 2026 Form 4: Blackburn Kelly, EVP, Clinical Development

Granted 30,000 Stock Option (Right to Buy)

13 Feb 2026 Form 4: Alam John J, Director

Granted 75,000 Stock Option (Right to Buy)

05 Dec 2025 Form 4: Quigley David, Director

Granted 16,200 Stock Option (Right to Buy)

19 Nov 2025 Form 4: Winton Matthew, Chief Commercial and Business

Bought 3,500 shares ($29.5K) · Bought 1,500 shares ($11.9K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support